The prevalence of P/LP BRCA1/2 gene mutations among the specific subgroup of triple negative (TN) disease was 33.9%, and it was 60% among patients with both TN disease and a family history of breast cancer as published by KHCC group [30]. Here, BRCA1 is linked to breast carcinoma.